Nelia P. Manamela
Johannesburg, GT, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease.
Journal: The Journal of infection
Published: October 28, 2025
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 22, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.
Journal: bioRxiv : the preprint server for biology
Published: February 03, 2025
SARS-CoV-2 vaccines elicit differential Fc effector functions.
Journal: iScience
Published: January 15, 2025
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
Journal: Journal of virology
Published: July 02, 2024
Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families.
Journal: PLoS pathogens
Published: April 19, 2024
Discovery and characterization of a pan-betacoronavirus S2-binding antibody.
Journal: Structure (London, England : 1993)
Published: February 05, 2024
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines.
Journal: Journal of virology
Published: December 12, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Journal: PLOS global public health
Published: December 04, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
Journal: medRxiv : the preprint server for health sciences
Published: December 04, 2023
Comparing the immune abnormalities in MIS-C to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell response.
Journal: Clinical immunology (Orlando, Fla.)
Published: September 04, 2023
Last Updated: 09/26/2026